Advances in the Pathogenesis and Therapeutics of Pulmonary Disease
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 30 June 2026 | Viewed by 38
Special Issue Editors
Interests: clinical investigation; translational research; pulmonology; allergology; cystic fibrosis
Special Issues, Collections and Topics in MDPI journals
Interests: pulmonology; noninvasive mechanical ventilation; respiratory failure; COPD
Special Issue Information
Dear Colleagues,
Pulmonary diseases, encompassing chronic obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis, lung cancer, and infectious pathologies like pneumonia, remain a leading cause of global morbidity and mortality. Despite significant progress, there is an urgent need to deepen our understanding of their underlying molecular mechanisms and to develop novel, effective therapeutic strategies.
This Special Issue aims to compile high-quality original research and review articles that illuminate novel aspects of disease etiology, progression, and host–pathogen interactions. We welcome contributions that explore innovative pharmacological targets, cutting-edge biomaterials for drug delivery, cell-based therapies, and repurposed drugs. The ultimate goal is to foster a comprehensive discussion on translating basic research findings into clinical applications, paving the way for improved patient outcomes across the spectrum of respiratory disorders.
Dr. Sara Manti
Dr. Paolo Ruggeri
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pulmonary diseases
- pathogenesis
- therapeutic targets
- drug discovery
- respiratory inflammation
- precision medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
